Related Experiment Videos
[Systemic capillary leak syndrome presenting remarkable erythrocytosis]
Daisuke Wakao1, Nobutaka Kawai, Yoshio Kuwayama
1First Department of Internal Medicine, Saitama Medical School.
Summary
Systemic capillary leak syndrome (SCLS) can present with severe erythrocytosis, mimicking polycythemia. Early recognition and treatment are crucial for managing this rare disorder.
Area of Science:
- Hematology
- Internal Medicine
- Rare Diseases
Background:
- Systemic capillary leak syndrome (SCLS) is a rare disorder characterized by plasma leakage, hypotension, edema, and hemoconcentration.
- Monoclonal gammopathy is often observed in SCLS patients.
- The exact mechanism of SCLS remains unknown.
Observation:
- A 30-year-old male presented with abdominal pain and markedly elevated hemoglobin (26.2 g/dl), initially suspected as pseudo-polycythemia due to hemoconcentration.
- The patient was diagnosed with SCLS based on the characteristic triad: increased hematocrit, generalized edema (pronounced in lower extremities), and monoclonal gammopathy.
- Recurrent SCLS attacks were observed despite initial recovery with fluid and albumin administration.
Findings:
- Treatment with extracellular fluids and albumin led to initial recovery.
- Prophylactic therapy including terbutaline sulfate, theophylline, and corticosteroids reduced the frequency of severe SCLS attacks.
- The case highlights SCLS as a critical differential diagnosis for erythrocytosis in hematology.
Implications:
- Hematologists should consider SCLS in patients presenting with unexplained erythrocytosis.
- Increased awareness of SCLS can lead to earlier diagnosis and appropriate management, potentially improving patient outcomes.
- Further research into SCLS mechanisms is needed to develop targeted therapies.